Estonian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
antiparkinson/turse
Link salvestatakse lõikelauale
10 tulemused
Anti-inflammatory, antioxidant, and antiparkinsonian effects of adenosine A2A receptor antagonists.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
The purpose of the study was to examine derivatives of annelated xanthines (imidazo-, pyrimido-, and diazepino-purinediones) for potential anti-inflammatory effects in carrageenan-induced paw edema in mice. Additionally, their antioxidant activity using the FRAP (ferric-reducing ability of plasma)
[Evaluation of the prolonged immunotropic effect of the potential antiparkinson agent himantane].
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
A prolonged immunotropic effect of himantane, a new potential antiparkinsonian drug with a multicomponent (including dopaminopositive) mechanism of action, upon the functional activity of splenic B-cells in mice was studied in comparison to the effect of a typical neuroleptic drug haloperidol. A
[Early pleuropulmonary toxicity associated with cabergoline, an antiparkinsonian drug].
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
We report a case of pleural effusion, pericardial thickening, and pulmonary involvement in a patient with dry cough, dyspnea, edema, and changes in the skin of the lower limbs. Treatment with cabergoline (Sogilen) had been started 4 months earlier. Pleural effusion, pericardial thickening, and
Adverse effects in the treatment of Parkinson's disease.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Side effects to antiparkinsonian drugs constitute an important component of the daily management of patients with Parkinson's disease. Treatment with levodopa frequently leads to motor fluctuations and dyskinesias. Hallucinosis, nausea and vomiting, drowsiness, orthostatic hypotension and peripheral
Four-year treatment of patients with parkinsonism using amantadine alone or with levodopa.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Half of 94 parkinsonian patients improved on amantadine therapy during acute double-blind trials. In a four-year follow-up, amantadine given alone or added to a stable dose of levodopa had its greatest effect in the first month and helped few patients after six months. Levodopa either alone or added
Stereotactic Gamma thalamotomy for the treatment of parkinsonism.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
From September 1994 to June 1995, eight patients with intractable parkinsonism underwent gamma thalamotomy in our hospital. All of these patients were male, with an average age of 59.3 years. The duration of the disease from initial diagnosis was 2-10 years (mean 6.8 years). All had failed or had
Efficacy and safety of amantadine for the treatment of L-DOPA-induced dyskinesia.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
L-DOPA induced dyskinesias (LIDs) may affect up to 40% of Parkinson's disease (PD) and impact negatively health-related quality of life. Amantadine has demonstrated significant antidyskinetic effects in animal PD models and in randomized double-blind placebo-controlled trials (RCTs) in patients with
Twice-daily, low-dose pramipexole in early Parkinson's disease: a randomized, placebo-controlled trial.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
To compare the safety and efficacy of low dosages of pramipexole given twice daily (bid) in early Parkinson's disease (PD) with those of a standard 3 times daily (tid) regimen in a randomized, double-blind, placebo controlled trial involving 311 early PD patients not receiving dopaminergic
Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND
The best way to initiate dopaminergic therapy for early Parkinson disease remains unclear.
OBJECTIVE
To compare initial treatment with pramipexole vs levodopa in early Parkinson disease, followed by levodopa supplementation, with respect to the development of dopaminergic motor
Isradipine Versus Placebo in Early Parkinson Disease: A Randomized Trial.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Kõige täiuslikum ravimtaimede andmebaas, mida toetab teadus
- Töötab 55 keeles
- Taimsed ravimid, mida toetab teadus
- Maitsetaimede äratundmine pildi järgi
- Interaktiivne GPS-kaart - märgistage ürdid asukohas (varsti)
- Lugege oma otsinguga seotud teaduspublikatsioone
- Otsige ravimtaimi nende mõju järgi
- Korraldage oma huvisid ja hoidke end kursis uudisteuuringute, kliiniliste uuringute ja patentidega
Sisestage sümptom või haigus ja lugege ravimtaimede kohta, mis võivad aidata, tippige ürdi ja vaadake haigusi ja sümptomeid, mille vastu seda kasutatakse.
* Kogu teave põhineb avaldatud teaduslikel uuringutel
